Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-tngx
/
Tango Therapeutics Inc
TNGX
Add to Watchlist
27.530
USD
-1.030
-3.61%
Close 07/20, 16:00(ET)
Quotes delayed by 15 min
27.718
USD
+27.718
After-hours 07/20, 20:00 (ET)
3.74B
Market Cap
Loss
P/E TTM
Tango Therapeutics Inc
27.530
-1.030
-3.61%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Farallon Capital Management, L.L.C.
9.06%
TCG Crossover Management, LLC
8.85%
Boxer Capital Management, LLC
7.54%
Adage Capital Management, L.P.
7.35%
Woodline Partners LP
6.98%
Other
60.22%
Shareholders
Shareholders
Proportion
Farallon Capital Management, L.L.C.
9.06%
TCG Crossover Management, LLC
8.85%
Boxer Capital Management, LLC
7.54%
Adage Capital Management, L.P.
7.35%
Woodline Partners LP
6.98%
Other
60.22%
Shareholder Types
Shareholders
Proportion
Hedge Fund
50.38%
Investment Advisor
38.33%
Investment Advisor/Hedge Fund
15.68%
Venture Capital
8.99%
Research Firm
4.63%
Individual Investor
1.31%
Family Office
0.49%
Private Equity
0.36%
Bank and Trust
0.18%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
357
177.88M
123.32%
+35.87M
2025Q4
328
133.54M
99.22%
-3.67M
2025Q3
309
124.59M
94.78%
+2.75M
2025Q2
313
119.32M
107.84%
-16.77M
2025Q1
320
116.84M
107.85%
-22.33M
2024Q4
310
116.06M
107.37%
-22.45M
2024Q3
292
115.54M
108.00%
-9.29M
2024Q2
286
112.62M
105.54%
-13.62M
2024Q1
280
112.63M
105.80%
-9.88M
2023Q4
261
107.66M
105.42%
-11.67M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Farallon Capital Management, L.L.C.
13.06M
9.15%
+2.30M
+21.42%
Dec 31, 2025
TCG Crossover Management, LLC
12.76M
8.94%
+4.23M
+49.51%
Dec 31, 2025
Boxer Capital Management, LLC
10.88M
7.62%
+1.10M
+11.31%
Dec 31, 2025
Adage Capital Management, L.P.
10.61M
7.43%
+8.10M
+322.46%
Dec 31, 2025
Woodline Partners LP
10.07M
7.06%
+4.04M
+67.04%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
7.76M
5.44%
+2.66M
+52.02%
Dec 31, 2025
Nextech Invest, Ltd.
7.27M
5.09%
+1.73M
+31.30%
Dec 31, 2025
Third Rock Ventures, LLC
6.37M
4.47%
-1.69M
-21.00%
Feb 06, 2026
State Street Investment Management (US)
6.22M
4.36%
+2.85M
+84.79%
Dec 31, 2025
Invus Public Equities Advisors, LLC
8.17M
5.72%
+2.28M
+38.79%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
1.09%
Invesco Dorsey Wright Healthcare Momentum ETF
0.95%
Invesco Dorsey Wright SmallCap Momentum ETF
0.91%
State Street SPDR S&P Biotech ETF
0.43%
Direxion Daily S&P Biotech Bull 3X Shares
0.18%
ProShares Ultra Nasdaq Biotechnology
0.15%
Vanguard US Momentum Factor ETF
0.12%
iShares Micro-Cap ETF
0.11%
Invesco Nasdaq Biotechnology ETF
0.09%
iShares Biotechnology ETF
0.05%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
1.09%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion
0.95%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion
0.91%
State Street SPDR S&P Biotech ETF
Proportion
0.43%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
0.18%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.15%
Vanguard US Momentum Factor ETF
Proportion
0.12%
iShares Micro-Cap ETF
Proportion
0.11%
Invesco Nasdaq Biotechnology ETF
Proportion
0.09%
iShares Biotechnology ETF
Proportion
0.05%